Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organogenesis Holdings (ORGO) Return on Sales: 2016-2024

Historic Return on Sales for Organogenesis Holdings (ORGO) over the last 9 years, with Dec 2024 value amounting to -0.02%.

  • Organogenesis Holdings' Return on Sales changed negligibly% to -0.02% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.02%, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of -0.02% for FY2024, which is 3.00% down from last year.
  • According to the latest figures from FY2024, Organogenesis Holdings' Return on Sales is -0.02%, which was down 279.13% from 0.01% recorded in FY2023.
  • In the past 5 years, Organogenesis Holdings' Return on Sales registered a high of 0.20% during FY2021, and its lowest value of -0.02% during FY2024.
  • In the last 3 years, Organogenesis Holdings' Return on Sales had a median value of 0.01% in 2023 and averaged 0.01%.
  • As far as peak fluctuations go, Organogenesis Holdings' Return on Sales grew by 20bps in 2020, and later fell by 17bps in 2022.
  • Organogenesis Holdings' Return on Sales (Yearly) stood at 0.05% in 2020, then grew by 15bps to 0.20% in 2021, then declined by 17bps to 0.03% in 2022, then fell by 2bps to 0.01% in 2023, then fell by 3bps to -0.02% in 2024.